|
GORASP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.157800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.166000E-01 |
| Normal-vs-Stage2 |
5.761000E-01 |
| Normal-vs-Stage3 |
5.889000E-01 |
| Normal-vs-Stage4 |
3.087000E-01 |
| Stage1-vs-Stage2 |
4.531400E-01 |
| Stage1-vs-Stage3 |
5.748600E-01 |
| Stage1-vs-Stage4 |
2.920600E-01 |
| Stage2-vs-Stage3 |
3.324200E-01 |
| Stage2-vs-Stage4 |
1.945760E-01 |
| Stage3-vs-Stage4 |
5.668800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.989000E-01 |
| Normal-vs-AfricanAmerican |
2.867600E-02 |
| Normal-vs-Asian |
1.397430E-01 |
| Caucasian-vs-AfricanAmerican |
1.998950E-03 |
| Caucasian-vs-Asian |
3.254800E-01 |
| AfricanAmerican-vs-Asian |
2.072000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.069600E-01 |
| Normal-vs-Female |
1.281960E-01 |
| Male-vs-Female |
1.910370E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.339000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.226200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.370000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.430000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.766200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.453200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.931600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.428400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.355400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.821000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.018000E-01 |
| Normal-vs-Grade 2 |
9.103200E-01 |
| Normal-vs-Grade 3 |
8.073800E-01 |
| Normal-vs-Grade 4 |
4.530400E-02 |
| Grade 1-vs-Grade 2 |
5.917800E-01 |
| Grade 1-vs-Grade 3 |
5.521200E-01 |
| Grade 1-vs-Grade 4 |
1.302640E-01 |
| Grade 2-vs-Grade 3 |
6.746600E-01 |
| Grade 2-vs-Grade 4 |
1.275530E-02 |
| Grade 3-vs-Grade 4 |
5.682500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.322200E-01 |
| Normal-vs-ccB subtype |
2.325400E-01 |
| ccA subtype-vs-ccB subtype |
2.419000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.681000E-01 |
| Normal-vs-N1 |
8.051900E-02 |
| N0-vs-N1 |
1.671450E-01 |
|
|
